Platelet-derived growth factor-BB accelerates prostate cancer growth by promoting the proliferation of mesenchymal stem cells

Journal of Cellular Biochemistry

Volumn 114, Issue 7, 2013, Pages 1510-1518

  Cheng, Jiwen ^a,b   Ye, Huama ^a   Liu, Zhiyong ^a   Xu, Chuanliang ^a   Zhang, Zhensheng ^a   Liu, Yan ^b   Sun, Yinghao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

MESENCHYMAL STEM CELLS (MSCs); PLATELET DERIVED GROWTH FACTOR BB (PDGF BB); PROSTATE CANCER

Indexed keywords

GAMMA INTERFERON; PLATELET DERIVED GROWTH FACTOR BB; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; FLOW CYTOMETRY; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-SIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; WOUND HEALING;

EID: 84877695000     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24492     Document Type: Article

References (29)

1. Andrae J, Gallini R, Betsholtz C,. 2008. Role of platelet-derived growth factors in physiology and medicine. Genes Develop 22: 1276-1312. (Pubitemid 351717519)
2. Badgett A, Bonner JC, Brody AR,. 1996. Interferon-gamma modulates lung macrophage production of PDGF-BB and fibroblast growth. J Lipid Mediat Cell Signal 13: 89-97.
3. Bird JL, Tyler JA,. 1995. Tumour necrosis factor alpha, interferon gamma and dexamethasone regulate IGF-I-maintained collagen production in cultured human fibroblasts. J Endocrinol 147: 167-176.
4. Bocelli-Tyndall C, Zajac P, Di Maggio N, Trella E, Benvenuto F, Iezzi G, Scherberich A, Barbero A, Schaeren S, Pistoia V, Spagnoli G, Vukcevic M, Martin I, Tyndall A,. 2010. Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Arthritis Rheum 62: 3815-3825.
5. Cheng P, Gao ZQ, Liu YH, Xue YX,. 2009. Platelet-derived growth factor BB promotes the migration of bone marrow-derived mesenchymal stem cells towards C6 glioma and up-regulates the expression of intracellular adhesion molecule-1. Neurosci Lett 451: 52-56.
6. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A,. 2006. Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372. (Pubitemid 43053565)
7. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM,. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99: 3838-3843. (Pubitemid 34534559)
8. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, Noel D, Jorgensen C,. 2003. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: 3837-3844. (Pubitemid 37409409)
9. Fang P, Hwa V, Little BM, Rosenfeld RG,. 2008. IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis. Growth Horm IGF Res 18: 38-46. (Pubitemid 351242572)
10. Freedland SJ, Isaacs WB,. 2005. Explaining racial differences in prostate cancer in the United States: Sociology or biology. Prostate 62: 243-252. (Pubitemid 40129062)
11. Han Z, Tian Z, Lv G, Zhang L, Jiang G, Sun K, Wang C, Bu X, Li R, Shi Y, Wu M, Wei L,. 2011. Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favors the growth of B16 melanoma cells. J Cell Mol Med 15: 2343-2352.
12. Hata N, Shinojima N, Gumin J, Yong R, Marini F, Andreeff M, Lang FF,. 2010. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas. Neurosurgery 66: 144-156; discussion 156-147.
13. Ikezumi Y, Atkins RC, Nikolic-Paterson DJ,. 2003. Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J Am Soc Nephrol 14: 888-898. (Pubitemid 36359271)
14. Jemal A, Siegel R, Xu J, Ward E,. 2010. Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
15. Kuno M, Takai S, Matsushima-Nishiwaki R, Minamitani C, Mizutani J, Otsuka T, Harada A, Adachi S, Kozawa O, Tokuda H,. 2009. Rho-kinase inhibitors decrease TGF-beta-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts. Biochem Pharmacol 77: 196-203.
16. Lederle W, Stark HJ, Skobe M, Fusenig NE, Mueller MM,. 2006. Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells. Am J Pathol 169: 1767-1783. (Pubitemid 351182007)
17. Mathew P, Tannir N, Tu SM, Wen S, Guo CC, Marcott V, Bekele BN, Pagliaro L,. 2011. Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: Observations with tandutinib. Cancer Chemother Pharmacol 68: 889-896.
18. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P,. 2010. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: Role of mesenchymal stem cell-derived TGF-beta. J Immunol 184: 5885-5894.
19. Placencio VR, Li X, Sherrill TP, Fritz G, Bhowmick NA,. 2010. Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth. PloS ONE 5: e12920.
20. Ramasamy R, Lam EW, Soeiro I, Tisato V, Bonnet D, Dazzi F,. 2007. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: Impact on in vivo tumor growth. Leukemia 21: 304-310. (Pubitemid 46158124)
21. Roskoski R, Jr., 2007. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critic Rev Oncol/Hematol 62: 179-213. (Pubitemid 46679285)
22. Shalita-Chesner M, Katz J, Shemer J, Werner H,. 2001. Regulation of insulin-like growth factor-I receptor gene expression by tumor necrosis factor-alpha and interferon-gamma. Mol Cell Endocrinol 176: 1-12. (Pubitemid 32454929)
23. Sotiropoulou PA, Papamichail M,. 2007. Immune properties of mesenchymal stem cells. Methods Mol Biol 407: 225-243.
24. Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A, Szyfter W, Zeromski J, Whiteside TL,. 2009. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 69: 3105-3113.
25. Tang YJ, Sun YH, Xu CL, Wang LH, Gao X, Liu B, Ji JT,. 2011. Prostate cancer cell line PC-3 conditioned medium promotes proliferation and osteogenic differentiation of human bone marrow mesenchymal stem cells. Zhonghua Nan Ke Xue 17: 229-236.
26. Uccelli A, Pistoia V, Moretta L,. 2007. Mesenchymal stem cells: A new strategy for immunosuppression. Trends Immunol 28: 219-226. (Pubitemid 46667240)
27. Wu F, Yang LY, Li YF, Ou DP, Chen DP, Fan C,. 2009. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology 50: 1839-1850.
28. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC,. 2009. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50: 1464-1474.
29. Yi B, Williams PJ, Niewolna M, Wang Y, Yoneda T,. 2002. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 62: 917-923. (Pubitemid 34126973)